FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/04/2023
Voltar para busca
Dado oficial do USPTO
X-ZONE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
19/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
09/06/2020
Data de registro
06/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/12/2022
Última transação
06/12/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Waiatarua Auckland, NZ
Examinador
BEN, LINDSEY
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EQUALITY PRODUCTS LIMITED
Representantes
Jeff Goehring NIXON & VANDERHYE P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Muscle pain relief and medicated performance gelscreamstopical sprays and roll ons; medicinal preparations for human use all in the form of balm; plant extracts for pharmaceutical purposes; medicinal herbs; medicinal oils; cannabis related productsoilssalvesconcentrated pastestincturestablets and capsuleseach containing cannabis or derivatives of cannabisresins and oils for medical or therapeutic purposeseach for the treatment of glaucomaarthritischronic back painburnsulcerswartsmolesmigraine headachesasthmainsomniaanxietydepressionstressloss of appetitefatiguegeneral painmuscle tensionjoint and muscle painmuscle crampsmuscle spasmsto enhance mood and to improve general state of well-being; nutraceuticals and herbs for medicinal purposes each containing cannabis and derivatives of cannabisresins and oilsfor the treatment of glaucomaarthritischronic back painburnsulcerswartsmolesmigraine headachesasthmainsomniaanxietydepressionstressloss of appetitefatiguegeneral painmuscle tensionjoint and muscle painmuscle crampsmuscle spasmsto enhance mood and to improve general state of well-being; analgesics; topical analgesic creams; antipyretic analgesics; anti-inflammatory analgesic plasters; pain relieving creams; pain relief preparations; multi-purpose medicated analgesic balms; effervescent analgesic pharmaceutical preparations; antiseptics; bath salts for medical purposes; bath preparations for medical purposes; herbal teas for medicinal purposes; medicated capillary lotions; medicated soap; medicated shampoos; medicinal tea; mineral waters for medical purposes; tissues impregnated with pharmaceutical skin lotions; mouthwashes for medical purposes; tinctures for medical purposes; oilssalvesconcentrated pastestincturestablets and capsules each containing resins and oils derived from cannabis for medical purposes for the treatment of glaucomaarthritischronic back painburnsulcerswartsmolesmigraine headachesasthmainsomniaanxietydepressionstressloss of appetitefatiguegeneral painmuscle tensionjoint and muscle painmuscle crampsmuscle spasmsto enhance mood and to improve general state of well-being; nutraceuticals for medicinal purposes containing derivatives of cannabisresins and oils; topical skin creams and gelsbar and liquid soapsbath additivesbath herbsbath oilsbody creamsbody oilsface and body lotionsface and body milkface lotionskin care preparations for medical purposes; oral sprays containing cannabis for medical purposes for use as central nervous system stimulants; topical creamslotionsbalmsoilsspraystransdermal patches for the relief of pain; medicinalherbal and botanical preparations and supplements all for medical purposes in the form of oil extractsoilsextractstincturesresinswaxeshashespastesbalmssalvesconcentrateslotionsspraysointmentspastestonicsliquidspowdersteascoffeesbeveragestopical skin creamslotions and gelspillstabletscapsulessuppositoriesskin patchessublingual dosesmucous membrane dosessprays and liquidstransdermal patches and oral spraysfor the treatment of glaucomaarthritischronic back painburnsulcerswartsmolesmigraine headachesasthmainsomniaanxietydepressionstressloss of appetitefatiguegeneral painmuscle tensionjoint and muscle painmuscle crampsmuscle spasmsto enhance mood and to improve general state of well-being; insect repellentsinsecticides and insect repellents; anti-fungal creams for medical use; fungicides; after-sun creams for medical use; medicated sun tanning preparations; aloe vera gel for therapeutic purposes; anti-bacterial throat sprays and mouth washes; medicated hair care preparations and lotions; decongestants; decongestant nasal sprays; medicated body and beauty care preparationspreparations in the form of creamsgels and lotionsall for the care of dry skin; dermatologicals for treatment of eczemapsoriasis and dermatological conditions; medicated bath and shower additives; medicated preparations for the care and cleaning of hair; medicated preparations for aged skinanti-aging creams and anti-aging serums; acne and skin blemish treatment medications; anti-itch creams and ointments; pharmaceutical preparations for the relief of insect bites; preparations for the treatment of burns; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; all of the aforementioned goods containing cannabis ingredients being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and no cannabidiol (CBD)
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/03/2023
FIMP
FINAL DISPOSITION PROCESSED
23/03/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/09/2022
PUBO
PUBLISHED FOR OPPOSITION
20/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/09/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/08/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/08/2022
ALIE
ASSIGNED TO LIE
15/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/08/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/08/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
19/04/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/03/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
30/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/03/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/03/2022
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
02/02/2022
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
02/02/2022
CNCF
ACTION CONTINUING A FINAL - COMPLETED
02/02/2022
NREV
NOTICE OF REVIVAL - E-MAILED
12/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2022
ALIE
ASSIGNED TO LIE
12/01/2022
PGRR
PETITION GRANTED - RESPONSE RECEIVED
12/01/2022
APET
ASSIGNED TO PETITION STAFF
11/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/11/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
16/11/2021
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
18/10/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
18/10/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/04/2021
GNFR
FINAL REFUSAL E-MAILED
06/04/2021
CNFR
FINAL REFUSAL WRITTEN
06/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/03/2021
RFNT
REFUSAL PROCESSED BY IB
15/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/02/2021
RFRR
REFUSAL PROCESSED BY MPU
25/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/02/2021
CNRT
NON-FINAL ACTION WRITTEN
16/02/2021
DOCK
ASSIGNED TO EXAMINER
08/02/2021
DOCK
ASSIGNED TO EXAMINER
09/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/11/2020
DOCK
ASSIGNED TO EXAMINER
02/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace X-ZONE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.